Sorafenib
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13777 publications
Correction: YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma.
Journal: Molecular cancer
Published: January 12, 2026
Expression and prognostic importance of lymphocyte activation gene 3 and CD73 in advanced or metastatic hepatocellular carcinoma.
Journal: The Journal of international medical research
Published: January 11, 2026
Glycomimetic Lysosome-targeting Chimeras (GLYTACs) for Degradation of Growth Factors and Growth Factor Receptors in Cancer Cells.
Journal: bioRxiv : the preprint server for biology
Published: January 09, 2026
Corrigendum to "Folic acid-functionalized and acetyl-terminated dendrimers as nanovectors for co-delivery of sorafenib and 5-fluorouracil" [Arch. Biochem. Biophys. 762C (2024) 110176].
Journal: Archives of biochemistry and biophysics
Published: January 08, 2026
Treatment Patterns and Survival Outcomes Among Patients With Hepatocellular Carcinoma.
Journal: JAMA network open
Published: December 30, 2025
Large extracellular vesicles regulate endothelial angiogenic potential via paracrine and autocrine signaling.
Journal: bioRxiv : the preprint server for biology
Published: December 25, 2025
Global evolution of ferroptosis research: a comprehensive bibliometric analysis of publication trends, geographic patterns, pharmacological innovation, and translational progress from inception through 2025.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: December 25, 2025
The Role of Saponin and its Nanoparticles on Malate Dehydrogenase Activity against Liver Cancer.
Journal: Cell biochemistry and biophysics
Published: December 23, 2025
A cost-effectiveness analysis of a new and more effective treatment for unresectable hepatocellular carcinoma-from a Chinese perspective.
Journal: Annals of medicine
Published: December 07, 2025
Peri-transplant conundrums: optimizing maintenance therapy using MRD-directed approaches.
Journal: Hematology. American Society of Hematology. Education Program
Published: December 05, 2025
RETRACTED: El-Masry et al. Potential Antitumor Activity of Combined Lycopene and Sorafenib Against Solid Ehrlich Carcinoma via Targeting Autophagy and Apoptosis and Suppressing Proliferation. Pharmaceuticals 2024, 17, 527.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 04, 2025
Last Updated: 02/24/2026